Comprehensive Overview of Sitagliptin for the Pharmacist: Clinical Insights and Evidence-Based Guidance

1. Introduction to Sitagliptin Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, marketed under the brand name Januvia® (and as Janumet® in combination with metformin). It is a cornerstone therapy in…

Continue ReadingComprehensive Overview of Sitagliptin for the Pharmacist: Clinical Insights and Evidence-Based Guidance

Dimethyl Fumarate: A Comprehensive Review for Pharmacists in the Management of Relapsing Multiple Sclerosis (MS)

1. Overview and Indications Dimethyl fumarate (DMF), marketed under the brand name Tecfidera, is an FDA-approved disease-modifying therapy (DMT) for adults with relapsing forms of multiple sclerosis (MS), including clinically…

Continue ReadingDimethyl Fumarate: A Comprehensive Review for Pharmacists in the Management of Relapsing Multiple Sclerosis (MS)

Cyclopentolate Hydrochloride Ophthalmic Solution: A Comprehensive Review for Pharmacists

1. Overview and Chemical Profile Cyclopentolate hydrochloride ophthalmic solution (CPH) is a topical mydriatic and cycloplegic agent widely used in ophthalmology to induce pupil dilation (mydriasis) and paralysis of the…

Continue ReadingCyclopentolate Hydrochloride Ophthalmic Solution: A Comprehensive Review for Pharmacists

ZERBAXA

What is ZERBAXA? ZERBAXA is a prescription antibiotic medication composed of two active ingredients: Ceftolozane: A next-generation cephalosporin antibiotic effective against a broad spectrum of Gram-negative bacteria, including multidrug-resistant strains…

Continue ReadingZERBAXA